Global Specialty Generics Market Report 2022: Improving Pharmaceutical Infrastructure in Developing Countries – Industry Analysis, Trends, Market Size, and Forecasts to 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Specialty Generics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027” report has been added to ResearchAndMarkets.com’s offering.

The report predicts the global specialty generics market to grow with a CAGR of 12.20% over the forecast period from 2021-2027.

The report on the global specialty generics market provides qualitative and quantitative analysis for the period from 2019 to 2027. The study on specialty generics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on specialty generics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global specialty generics market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global specialty generics market over the period of 2019 to 2027. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

• Rise in the incidences of chronic diseases
• Growing cases of HIV/AIDS

2) Restraints

• Complex and expensive R&D processes

3) Opportunities

• Improving pharmaceutical infrastructure in developing countries

Company Profiles

The companies covered in the report include:

• Valeant Pharmaceuticals International, Inc.
• Novartis
• Pfizer Inc.
• Turing Pharmaceuticals
• Teva Pharmaceutical Ltd.
• Mylan N.V.
• Akorn, Inc.,
• Mallinckrodt
• Sun Pharma
• Others

Key Topics Covered:

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Specialty Generics Market Highlights

2.2. Specialty Generics Market Projection

2.3. Specialty Generics Market Regional Highlights

3. Global Specialty Generics Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Analysis of COVID-19 impact on the Specialty Generics Market

3.4. Porter’s Five Forces Analysis

3.5. Growth Matrix Analysis

3.5.1. Growth Matrix Analysis by Type

3.5.2. Growth Matrix Analysis by Application

3.5.3. Growth Matrix Analysis by Distribution Channel

3.5.4. Growth Matrix Analysis by Region

3.6. Value Chain Analysis of Specialty Generics Market

4. Specialty Generics Market Macro Indicator Analysis

5. Global Specialty Generics Market by Type

5.1. Injectables

5.2. Oral

5.3. Others

6. Global Specialty Generics Market by Application

6.1. Oncology

6.2. Infectious Diseases

6.3. Autoimmune Diseases

6.4. Others

7. Global Specialty Generics Market by Distribution Channel

7.1. Specialty Pharmacies

7.2. Retail Pharmacies

7.3. Hospital Pharmacies

8. Global Specialty Generics Market by Region 2021-2027

8.1. North America

8.1.1. North America Specialty Generics Market by Type

8.1.2. North America Specialty Generics Market by Application

8.1.3. North America Specialty Generics Market by Distribution Channel

8.1.4. North America Specialty Generics Market by Country

8.2. Europe

8.3. Asia-Pacific

8.4. RoW

9. Company Profiles and Competitive Landscape

9.1. Competitive Landscape in the Global Specialty Generics Market

9.2. Companies Profiled

For more information about this report visit https://www.researchandmarkets.com/r/v0i18q.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900